WAM
ANIK icon

Wealthspire Advisors (Maryland)’s Anika Therapeutics ANIK Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed – – 540
2019
Q1 		$0 Hold
8
– – ﹤0.01% 2469
2018
Q4 		$0 Sell
8
-40
-83% -$1.44K ﹤0.01% 2423
2018
Q3 		$2K Sell
48
-3
-6% -$119 ﹤0.01% 2123
2018
Q2 		$2K Buy
51
+17
+50% +$700 ﹤0.01% 2116
2018
Q1 		$2K Sell
34
-88
-72% -$4.97K ﹤0.01% 2127
2017
Q4 		$7K Buy
122
+28
+30% +$1.55K ﹤0.01% 1714
2017
Q3 		$5K Buy
94
+2
+2% +$105 ﹤0.01% 1780
2017
Q2 		$5K Buy
+92
New +$4.24K ﹤0.01% 1747

Other funds holding ANIK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return